Disclosures for "Smartphone Pupillometry Use in Neurodegenerative Disease: A Clinical Pilot Study"
-
Mr. Maxin has stock in Apertur, Inc.
-
Ms. Kush has nothing to disclose.
-
Ms. Kehne has nothing to disclose.
-
Mr. Nilchian has nothing to disclose.
-
Dr. Gulek has nothing to disclose.
-
Dr. McGrath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Football League. Dr. McGrath has received personal compensation in the range of $0-$499 for serving as a Consultant for joimax. Dr. McGrath has stock in Apertur, Inc. Dr. McGrath has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Dr. Grabowski has received research support from NIH.
-
Dr. Levitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Levitt has received personal compensation in the range of $0-$499 for serving as a Consultant for Metis Innovative. Dr. Levitt has received personal compensation in the range of $0-$499 for serving as a Consultant for Aeaean Consulting, LLC. Dr. Levitt has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of NeuroInterventional Surgery. Dr. Levitt has received stock or an ownership interest from Proprio. Dr. Levitt has received stock or an ownership interest from Synchron. Dr. Levitt has received stock or an ownership interest from Cerebrotech. Dr. Levitt has received stock or an ownership interest from Hyperion Surgical. The institution of Dr. Levitt has received research support from Medtronic. The institution of Dr. Levitt has received research support from Stryker. Dr. Levitt has received publishing royalties from a publication relating to health care.